David R. Doherty

Statistics

Publications

Citations

112

H-Index

Active since

2009

Affiliations

Amgen (United States)(Current)

David R. Doherty is an author at Amgen (United States) specializing in procollagen iii peptide, connective tissue disorders, and placebo-controlled efficacy assessment.

Publications per year

2009–2019

Publications

Application of Locked Nucleic Acid Oligonucleotides for siRNA Preclinical Bioanalytics

Mai B. Thayer, Julie M. Lade, David R. Doherty et al. · Scientific Reports · 2019 · 44 citations · Full text

Life Sciences, Biotechnology, Molecular Biology +14

Clinical pharmacology of <scp>AMG</scp> 181, a gut‐specific human anti‐α<sub>4</sub>β<sub>7</sub> monoclonal antibody, for treating inflammatory bowel diseases

Wei‐Jian Pan, Kathleen Köck, William A. Rees et al. · British Journal of Clinical Pharmacology · 2014 · 35 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

“Fit-for-Purpose” Method Validation and Application of a Biomarker (C-terminal Telopeptides of Type 1 Collagen) in Denosumab Clinical Studies

Jin Wang, Jean Lee, Daniel K. Burns et al. · The AAPS Journal · 2009 · 33 citations · Full text

Medicine, Clinical Sciences, Molecular Medicine +12

1–3 of 3